http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003069207-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
filingDate 2002-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c384487f4fb649581ab41db2f61cc95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87b9d4ab7e2b8c89279df9cfae3c24e
publicationDate 2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2003069207-A1
titleOfInvention Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
abstract The invention relates to new formulations for improving the local tolerance of intravenously administered 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine or one of the pharmacologically acceptable acid addition salts thereof.
priorityDate 2001-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6407079-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6323207-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5324750-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246761572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127948170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9868115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127517024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9935892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53836292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227512072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158233450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136334291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23617285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227512059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142530329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231723492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246884853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9868114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231723494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID138977953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129620824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457865216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449018088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135859566

Total number of triples: 57.